首页 > 最新文献

International Journal of Medical Informatics最新文献

英文 中文
Automatic (near-) duplicate content document detection in a cancer registry
IF 3.7 2区 医学 Q2 COMPUTER SCIENCE, INFORMATION SYSTEMS Pub Date : 2025-01-18 DOI: 10.1016/j.ijmedinf.2025.105799
Tapio Niemi, Jean Pierre Ghobril, Gautier Defossez, Simon Germann, Eloïse Martin, Jean-Luc Bulliard

Background

Duplicate and near-duplicate medical documents are problematic in document management, clinical use, and medical research. In this study, we focus on multisourced medical documents in the context of a population-based cancer registry in Switzerland. Although the data collection process is well-regulated, the volume of transmitted documents steadily increases and the presence of full or near-duplicates slows down and complicates document processing. Identifying near-duplicates is particularly challenging because the large number of documents makes pairwise comparison non-feasible.

Methods

We implemented a system based on both normal hash functions, Simhash (Locality Sensitive Hashing), and Smith-Waterman text alignment similarity. Simhash offers good performance and confirming its results by the Smith-Waterman algorithm with a selected similarity threshold reduces the false positive rate to near zero without lowering sensitivity. Extracted differences in near-duplicate content documents are shown by highlighting differences in original PDF documents.
We validated the method using 3042 manually verified document pairs containing 1252 full-duplicate and 398 near-duplicate pairs. The area under the curve (AUC) was 0.96, sensitivity 0.92, specificity 1.00, PPV 1.00, and NPV 0.91. For the same size simulated data, corresponding values were 0.86, 0.72, 1.00, 1.00, and 0.77, respectively.

Results

We applied the method against 224,398 medical documents in the cancer registry. We found 5.5% of duplicates on the text level, and 0.17–0.24% near-duplicates depending on the used parameters and threshold values. Most near-duplicates related to the same patient and originated from the same transmitter. Manual evaluation showed that only 2% of differences were in medical contents and 83% in administrative data (21% in patient, 11% in doctor, and 51% in other administrative data). Many near-duplicates looked strikingly similar from a human perspective.

Conclusions

We demonstrated that our method can efficiently find all full-duplicates and most near-duplicates in a large set of multisourced medical documents. Potential ways to further improve this method are discussed. The method can be applied to documents in all domains.
{"title":"Automatic (near-) duplicate content document detection in a cancer registry","authors":"Tapio Niemi,&nbsp;Jean Pierre Ghobril,&nbsp;Gautier Defossez,&nbsp;Simon Germann,&nbsp;Eloïse Martin,&nbsp;Jean-Luc Bulliard","doi":"10.1016/j.ijmedinf.2025.105799","DOIUrl":"10.1016/j.ijmedinf.2025.105799","url":null,"abstract":"<div><h3>Background</h3><div>Duplicate and near-duplicate medical documents are problematic in document management, clinical use, and medical research. In this study, we focus on multisourced medical documents in the context of a population-based cancer registry in Switzerland. Although the data collection process is well-regulated, the volume of transmitted documents steadily increases and the presence of full or near-duplicates slows down and complicates document processing. Identifying near-duplicates is particularly challenging because the large number of documents makes pairwise comparison non-feasible.</div></div><div><h3>Methods</h3><div>We implemented a system based on both normal hash functions, Simhash (Locality Sensitive Hashing), and Smith-Waterman text alignment similarity. Simhash offers good performance and confirming its results by the Smith-Waterman algorithm with a selected similarity threshold reduces the false positive rate to near zero without lowering sensitivity. Extracted differences in near-duplicate content documents are shown by highlighting differences in original PDF documents.</div><div>We validated the method using 3042 manually verified document pairs containing 1252 full-duplicate and 398 near-duplicate pairs. The area under the curve (AUC) was 0.96, sensitivity 0.92, specificity 1.00, PPV 1.00, and NPV 0.91. For the same size simulated data, corresponding values were 0.86, 0.72, 1.00, 1.00, and 0.77, respectively.</div></div><div><h3>Results</h3><div>We applied the method against 224,398 medical documents in the cancer registry. We found 5.5% of duplicates on the text level, and 0.17–0.24% near-duplicates depending on the used parameters and threshold values. Most near-duplicates related to the same patient and originated from the same transmitter. Manual evaluation showed that only 2% of differences were in medical contents and 83% in administrative data (21% in patient, 11% in doctor, and 51% in other administrative data). Many near-duplicates looked strikingly similar from a human perspective.</div></div><div><h3>Conclusions</h3><div>We demonstrated that our method can efficiently find all full-duplicates and most near-duplicates in a large set of multisourced medical documents. Potential ways to further improve this method are discussed. The method can be applied to documents in all domains.</div></div>","PeriodicalId":54950,"journal":{"name":"International Journal of Medical Informatics","volume":"195 ","pages":"Article 105799"},"PeriodicalIF":3.7,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143025602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of an ANCA-associated vasculitis cohort using deep learning and electronic health records
IF 3.7 2区 医学 Q2 COMPUTER SCIENCE, INFORMATION SYSTEMS Pub Date : 2025-01-17 DOI: 10.1016/j.ijmedinf.2025.105797
Liqin Wang , John Novoa-Laurentiev , Claire Cook , Shruthi Srivatsan , Yining Hua , Jie Yang , Eli Miloslavsky , Hyon K. Choi , Li Zhou , Zachary S. Wallace

Background

ANCA-associated vasculitis (AAV) is a rare but serious disease. Traditional case-identification methods using claims data can be time-intensive and may miss important subgroups. We hypothesized that a deep learning model analyzing electronic health records (EHR) can more accurately identify AAV cases.

Methods

We examined the Mass General Brigham (MGB) repository of clinical documentation from 12/1/1979 to 5/11/2021, using expert-curated keywords and ICD codes to identify a large cohort of potential AAV cases. Three labeled datasets (I, II, III) were created, each containing note sections. We trained and evaluated a range of machine learning and deep learning algorithms for note-level classification, using metrics like positive predictive value (PPV), sensitivity, F-score, area under the receiver operating characteristic curve (AUROC), and area under the precision and recall curve (AUPRC). The hierarchical attention network (HAN) was further evaluated for its ability to classify AAV cases at the patient-level, compared with rule-based algorithms in 2000 randomly chosen samples.

Results

Datasets I, II, and III comprised 6000, 3008, and 7500 note sections, respectively. HAN achieved the highest AUROC in all three datasets, with scores of 0.983, 0.991, and 0.991. The deep learning approach also had among the highest PPVs across the three datasets (0.941, 0.954, and 0.800, respectively). In a test cohort of 2000 cases, the HAN model achieved a PPV of 0.262 and an estimated sensitivity of 0.975. Compared to the best rule-based algorithm, HAN identified six additional AAV cases, representing 13% of the total.

Conclusion

The deep learning model effectively classifies clinical note sections for AAV diagnosis. Its application to EHR notes can potentially uncover additional cases missed by traditional rule-based methods.
{"title":"Identification of an ANCA-associated vasculitis cohort using deep learning and electronic health records","authors":"Liqin Wang ,&nbsp;John Novoa-Laurentiev ,&nbsp;Claire Cook ,&nbsp;Shruthi Srivatsan ,&nbsp;Yining Hua ,&nbsp;Jie Yang ,&nbsp;Eli Miloslavsky ,&nbsp;Hyon K. Choi ,&nbsp;Li Zhou ,&nbsp;Zachary S. Wallace","doi":"10.1016/j.ijmedinf.2025.105797","DOIUrl":"10.1016/j.ijmedinf.2025.105797","url":null,"abstract":"<div><h3>Background</h3><div>ANCA-associated vasculitis (AAV) is a rare but serious disease. Traditional case-identification methods using claims data can be time-intensive and may miss important subgroups. We hypothesized that a deep learning model analyzing electronic health records (EHR) can more accurately identify AAV cases.</div></div><div><h3>Methods</h3><div>We examined the Mass General Brigham (MGB) repository of clinical documentation from 12/1/1979 to 5/11/2021, using expert-curated keywords and ICD codes to identify a large cohort of potential AAV cases. Three labeled datasets (I, II, III) were created, each containing note sections. We trained and evaluated a range of machine learning and deep learning algorithms for note-level classification, using metrics like positive predictive value (PPV), sensitivity, F-score, area under the receiver operating characteristic curve (AUROC), and area under the precision and recall curve (AUPRC). The hierarchical attention network (HAN) was further evaluated for its ability to classify AAV cases at the patient-level, compared with rule-based algorithms in 2000 randomly chosen samples.</div></div><div><h3>Results</h3><div>Datasets I, II, and III comprised 6000, 3008, and 7500 note sections, respectively. HAN achieved the highest AUROC in all three datasets, with scores of 0.983, 0.991, and 0.991. The deep learning approach also had among the highest PPVs across the three datasets (0.941, 0.954, and 0.800, respectively). In a test cohort of 2000 cases, the HAN model achieved a PPV of 0.262 and an estimated sensitivity of 0.975. Compared to the best rule-based algorithm, HAN identified six additional AAV cases, representing 13% of the total.</div></div><div><h3>Conclusion</h3><div>The deep learning model effectively classifies clinical note sections for AAV diagnosis. Its application to EHR notes can potentially uncover additional cases missed by traditional rule-based methods.</div></div>","PeriodicalId":54950,"journal":{"name":"International Journal of Medical Informatics","volume":"196 ","pages":"Article 105797"},"PeriodicalIF":3.7,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143048871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The use of Artificial Intelligence Algorithms in drug development and clinical trials: A scoping review 人工智能算法在药物开发和临床试验中的应用:范围综述。
IF 3.7 2区 医学 Q2 COMPUTER SCIENCE, INFORMATION SYSTEMS Pub Date : 2025-01-16 DOI: 10.1016/j.ijmedinf.2025.105798
Camila de Brito Pontes , Antonio Valerio Netto
Background: Artificial Intelligence (AI) is transforming drug development and clinical trials, helping researchers find new treatments faster and personalize care for patients. By automating tasks like molecule screening and predicting treatment outcomes, AI addresses critical challenges in modern medicine. Objectives: This review explores how AI is being used in drug development and clinical trials, focusing on its benefits, limitations, and potential to improve healthcare outcomes. Methods: A scoping review based on Arksey and O’Malley’s, 2005 framework was conducted, analyzing 1,956 studies from PubMed, Web of Science, IEEE Xplore, and Scopus. Ten studies were selected for in-depth analysis. Results: Common AI techniques include Support Vector Machines, Neural Networks, and Random Forests, applied in tasks such as identifying new drug uses, predicting antibiotic resistance, and streamlining clinical trials. While AI has shown great promise, challenges like inconsistent data quality and difficulties in clinical validation remain. Conclusions: AI offers exciting opportunities to improve healthcare by making drug development and clinical trials more efficient. However, overcoming barriers like data integration and methodological standardization is essential to ensure these tools benefit diverse populations, especially in settings like Brazil, where genetic diversity and health inequalities pose unique challenges.
背景:人工智能(AI)正在改变药物开发和临床试验,帮助研究人员更快地找到新的治疗方法,并为患者提供个性化护理。通过自动化分子筛选和预测治疗结果等任务,人工智能解决了现代医学中的关键挑战。目的:本综述探讨了人工智能在药物开发和临床试验中的应用,重点关注其益处、局限性和改善医疗保健结果的潜力。方法:基于Arksey和O'Malley的2005框架进行范围综述,分析了PubMed、Web of Science、IEEE explore和Scopus中的1956项研究。选取10项研究进行深入分析。结果:常见的人工智能技术包括支持向量机、神经网络和随机森林,应用于识别新药用途、预测抗生素耐药性和简化临床试验等任务。虽然人工智能显示出巨大的前景,但数据质量不一致和临床验证困难等挑战仍然存在。结论:人工智能通过提高药物开发和临床试验的效率,为改善医疗保健提供了令人兴奋的机会。然而,克服数据整合和方法标准化等障碍对于确保这些工具惠及不同人群至关重要,特别是在遗传多样性和健康不平等构成独特挑战的巴西等国家。
{"title":"The use of Artificial Intelligence Algorithms in drug development and clinical trials: A scoping review","authors":"Camila de Brito Pontes ,&nbsp;Antonio Valerio Netto","doi":"10.1016/j.ijmedinf.2025.105798","DOIUrl":"10.1016/j.ijmedinf.2025.105798","url":null,"abstract":"<div><div>Background: Artificial Intelligence (AI) is transforming drug development and clinical trials, helping researchers find new treatments faster and personalize care for patients. By automating tasks like molecule screening and predicting treatment outcomes, AI addresses critical challenges in modern medicine. Objectives: This review explores how AI is being used in drug development and clinical trials, focusing on its benefits, limitations, and potential to improve healthcare outcomes. Methods: A scoping review based on Arksey and O’Malley’s, 2005 framework was conducted, analyzing 1,956 studies from PubMed, Web of Science, IEEE Xplore, and Scopus. Ten studies were selected for in-depth analysis. Results: Common AI techniques include Support Vector Machines, Neural Networks, and Random Forests, applied in tasks such as identifying new drug uses, predicting antibiotic resistance, and streamlining clinical trials. While AI has shown great promise, challenges like inconsistent data quality and difficulties in clinical validation remain. Conclusions: AI offers exciting opportunities to improve healthcare by making drug development and clinical trials more efficient. However, overcoming barriers like data integration and methodological standardization is essential to ensure these tools benefit diverse populations, especially in settings like Brazil, where genetic diversity and health inequalities pose unique challenges.</div></div>","PeriodicalId":54950,"journal":{"name":"International Journal of Medical Informatics","volume":"195 ","pages":"Article 105798"},"PeriodicalIF":3.7,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing information for action: A strategic tool for strengthening public health emergency management systems
IF 3.7 2区 医学 Q2 COMPUTER SCIENCE, INFORMATION SYSTEMS Pub Date : 2025-01-16 DOI: 10.1016/j.ijmedinf.2025.105791
Catherine Smallwood , Carlos Matos , Hugo Monteiro , Mark Shapiro , Miranda Tran Ngoc , Mohamed Elamein , Raviv Raz , Samuel Petragallo

Background

This paper addresses the importance of timely and robust information systems that underpin emergency response decision-making, as evidenced during the COVID-19 pandemic in the WHO European Region. Recognizing the relevance of these systems, we propose the strengthening of national emergency response information management systems (ERIMS) within the broader digital health information system (HIS) framework. We aim to develop and present an innovative assessment tool designed to evaluate and assist in the strengthening of ERIMS, contributing to a more resilient and effective emergency response.

Methods

This study presents the development of an ERIMS assessment tool using a systems-based approach and defined standards by the WHO Regional Office for Europe. The tool provides a systematic methodology to evaluate and enhance a country’s ERIMS capacity, and is designed to accommodate different information system architecture, emergency response coordination mechanisms, and digitalisation levels. The development process involved consultations with experts in digital health, emergency management, and public health policy, as well as lessons identified through pilot implementation of the assessment tool in several countries.

Main findings

The application of this tool revealed gaps in existing ERIMS and highlighted the importance of digital transformation in emergency management practices. The tool facilitated the identification of priority areas for improvement and supported the establishment of best practices and international standards for digital health initiatives that relate to emergency management.

Conclusions

This assessment tool represents a contribution to the field of digital health and emergency management. It offers a way for countries to enhance their emergency response capabilities, focusing on information for action. By improving ERIMS, countries can ensure better preparedness, timely response and effective recovery from health emergencies, thereby strengthening global health security in the face of future challenges.
{"title":"Enhancing information for action: A strategic tool for strengthening public health emergency management systems","authors":"Catherine Smallwood ,&nbsp;Carlos Matos ,&nbsp;Hugo Monteiro ,&nbsp;Mark Shapiro ,&nbsp;Miranda Tran Ngoc ,&nbsp;Mohamed Elamein ,&nbsp;Raviv Raz ,&nbsp;Samuel Petragallo","doi":"10.1016/j.ijmedinf.2025.105791","DOIUrl":"10.1016/j.ijmedinf.2025.105791","url":null,"abstract":"<div><h3>Background</h3><div>This paper addresses the importance of timely and robust information systems that underpin emergency response decision-making, as evidenced during the COVID-19 pandemic in the WHO European Region. Recognizing the relevance of these systems, we propose the strengthening of national emergency response information management systems (ERIMS) within the broader digital health information system (HIS) framework. We aim to develop and present an innovative assessment tool designed to evaluate and assist in the strengthening of ERIMS, contributing to a more resilient and effective emergency response.</div></div><div><h3>Methods</h3><div>This study presents the development of an ERIMS assessment tool using a systems-based approach and defined standards by the WHO Regional Office for Europe. The tool provides a systematic methodology to evaluate and enhance a country’s ERIMS capacity, and is designed to accommodate different information system architecture, emergency response coordination mechanisms, and digitalisation levels. The development process involved consultations with experts in digital health, emergency management, and public health policy, as well as lessons identified through pilot implementation of the assessment tool in several countries.</div></div><div><h3>Main findings</h3><div>The application of this tool revealed gaps in existing ERIMS and highlighted the importance of digital transformation in emergency management practices. The tool facilitated the identification of priority areas for improvement and supported the establishment of best practices and international standards for digital health initiatives that relate to emergency management.</div></div><div><h3>Conclusions</h3><div>This assessment tool represents a contribution to the field of digital health and emergency management. It offers a way for countries to enhance their emergency response capabilities, focusing on information for action. By improving ERIMS, countries can ensure better preparedness, timely response and effective recovery from health emergencies, thereby strengthening global health security in the face of future challenges.</div></div>","PeriodicalId":54950,"journal":{"name":"International Journal of Medical Informatics","volume":"196 ","pages":"Article 105791"},"PeriodicalIF":3.7,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143043383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ICT acceptance in social and healthcare context – A scoping review of theories and models 信息通信技术在社会和医疗保健方面的接受——理论和模型的范围审查。
IF 3.7 2区 医学 Q2 COMPUTER SCIENCE, INFORMATION SYSTEMS Pub Date : 2025-01-15 DOI: 10.1016/j.ijmedinf.2025.105796
Heli Kumpulainen , Ulla-Mari Kinnunen , Virpi Jylhä

Background

Although Information and Communication Technology (ICT) acceptance processes have been studied widely in the social and healthcare context, the theoretical background of these studies is widely based on Technology Acceptance Models (TAM, TAM2, UTAUT) and their extensions. These theoretical models have been criticized for being overly simplistic and focusing narrowly on individual adopters’ beliefs, perceptions, and usage intentions without considering multidimensional approaches to capture the complexity of certain phenomena. Thus, there is a need for identifying other approaches to study ICT acceptance in the complex and digitalizing social and health care context.

Aim

The aim of this review is to identify and describe existing theories and models of ICT acceptance studies, other than TAM and UTAUT, in the social and health care context. In addition, the aim is to identify and classify the dimensions of ICT acceptance within these theories and models.

Methods

JBI methodology for scoping reviews was used as guidance. A literature search was done on four electronic databases (PubMed, Scopus, Web of Science and CINAHL). The reporting was conducted by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for the scoping review (PRISMA-ScR). Further, descriptive statistics and inductive content analysis were used to analyse the theories, models and dimensions of ICT acceptance within them.

Results

21 studies were included in this review. Results indicated that ICT acceptance in the social and healthcare context have been studied by using a variety of theories and models from different disciplines. Within these theories and models, organization, technology, human, sociocultural and environment were identified as the main dimensions of ICT acceptance in the social and healthcare context.

Conclusions

This review provides an overview of the alternative theories and models of ICT acceptance and dimensions to be considered when assessing ICT acceptance in the social and healthcare context.
背景:虽然信息和通信技术(ICT)的接受过程在社会和医疗环境中得到了广泛的研究,但这些研究的理论背景广泛基于技术接受模型(TAM, TAM2, UTAUT)及其扩展。这些理论模型被批评为过于简单化,并且狭隘地关注个体采用者的信念、感知和使用意图,而没有考虑多维方法来捕捉某些现象的复杂性。因此,有必要确定其他方法来研究在复杂和数字化的社会和保健背景下对信息通信技术的接受情况。目的:本综述的目的是确定和描述除TAM和UTAUT外,在社会和卫生保健背景下ICT接受研究的现有理论和模型。此外,目的是在这些理论和模型中识别和分类信息通信技术接受的维度。方法:采用JBI方法进行范围评价。在PubMed、Scopus、Web of Science和CINAHL四个电子数据库上进行文献检索。报告由系统评价和荟萃分析扩展的首选报告项目(PRISMA-ScR)进行。在此基础上,采用描述性统计和归纳性内容分析的方法,对信息通信技术接受度的理论、模型和维度进行了分析。结果:本综述纳入了21项研究。结果表明,通过使用来自不同学科的各种理论和模型,研究了社会和医疗保健背景下的信息通信技术接受情况。在这些理论和模型中,组织、技术、人、社会文化和环境被确定为社会和保健环境中信息通信技术接受程度的主要方面。结论:本综述概述了信息通信技术接受的替代理论和模型,以及在社会和医疗保健背景下评估信息通信技术接受时需要考虑的维度。
{"title":"ICT acceptance in social and healthcare context – A scoping review of theories and models","authors":"Heli Kumpulainen ,&nbsp;Ulla-Mari Kinnunen ,&nbsp;Virpi Jylhä","doi":"10.1016/j.ijmedinf.2025.105796","DOIUrl":"10.1016/j.ijmedinf.2025.105796","url":null,"abstract":"<div><h3>Background</h3><div>Although Information and Communication Technology (ICT) acceptance processes have been studied widely in the social and healthcare context, the theoretical background of these studies is widely based on Technology Acceptance Models (TAM, TAM2, UTAUT) and their extensions. These theoretical models have been criticized for being overly simplistic and focusing narrowly on individual adopters’ beliefs, perceptions, and usage intentions without considering multidimensional approaches to capture the complexity of certain phenomena. Thus, there is a need for identifying other approaches to study ICT acceptance in the complex and digitalizing social and health care context.</div></div><div><h3>Aim</h3><div>The aim of this review is to identify and describe existing theories and models of ICT acceptance studies, other than TAM and UTAUT, in the social and health care context. In addition, the aim is to identify and classify the dimensions of ICT acceptance within these theories and models.</div></div><div><h3>Methods</h3><div>JBI methodology for scoping reviews was used as guidance. A literature search was done on four electronic databases (PubMed, Scopus, Web of Science and CINAHL). The reporting was conducted by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for the scoping review (PRISMA-ScR). Further, descriptive statistics and inductive content analysis were used to analyse the theories, models and dimensions of ICT acceptance within them.</div></div><div><h3>Results</h3><div>21 studies were included in this review. Results indicated that ICT acceptance in the social and healthcare context have been studied by using a variety of theories and models from different disciplines. Within these theories and models, organization, technology, human, sociocultural and environment were identified as the main dimensions of ICT acceptance in the social and healthcare context.</div></div><div><h3>Conclusions</h3><div>This review provides an overview of the alternative theories and models of ICT acceptance and dimensions to be considered when assessing ICT acceptance in the social and healthcare context.</div></div>","PeriodicalId":54950,"journal":{"name":"International Journal of Medical Informatics","volume":"195 ","pages":"Article 105796"},"PeriodicalIF":3.7,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reducing reading time and assessing disease in capsule endoscopy videos: A deep learning approach 缩短胶囊内窥镜视频的阅读时间和评估疾病:一种深度学习方法。
IF 3.7 2区 医学 Q2 COMPUTER SCIENCE, INFORMATION SYSTEMS Pub Date : 2025-01-14 DOI: 10.1016/j.ijmedinf.2025.105792
Luís Pinto , Isabel N. Figueiredo , Pedro N. Figueiredo

Background

The wireless capsule endoscope (CE) is a valuable diagnostic tool in gastroenterology, offering a safe and minimally invasive visualization of the gastrointestinal tract. One of the few drawbacks identified by the gastroenterology community is the time-consuming task of analyzing CE videos.

Objectives

This article investigates the feasibility of a computer-aided diagnostic method to speed up CE video analysis. We aim to generate a significantly smaller CE video with all the anomalies (i.e., diseases) identified by the medical doctors in the original video.

Methods

The summarized video consists of the original video frames classified as anomalous by a pre-trained convolutional neural network (CNN). We evaluate our approach on a testing dataset with eight CE videos captured with five CE types and displaying multiple anomalies.

Results

On average, the summarized videos contain 93.33% of the anomalies identified in the original videos. The average playback time of the summarized videos is just 10 min, compared to 58 min for the original videos.

Conclusion

Our findings demonstrate the potential of deep learning-aided diagnostic methods to accelerate CE video analysis.
背景:无线胶囊内窥镜(CE)是一种有价值的胃肠病学诊断工具,提供了安全和微创的胃肠道可视化。胃肠病学社区确定的少数缺点之一是分析CE视频的耗时任务。目的:探讨一种计算机辅助诊断方法加快CE视频分析的可行性。我们的目标是生成一个明显更小的CE视频,其中包含原始视频中医生识别的所有异常(即疾病)。方法:将经过预训练的卷积神经网络(CNN)分类为异常的原始视频帧组成摘要视频。我们在一个测试数据集上评估了我们的方法,该数据集使用五种CE类型捕获的八个CE视频并显示多个异常。结果:平均而言,总结视频中原始视频中识别的异常率为93.33%。摘要视频的平均播放时间仅为10分钟,而原始视频的平均播放时间为58分钟。结论:我们的研究结果证明了深度学习辅助诊断方法在加速CE视频分析方面的潜力。
{"title":"Reducing reading time and assessing disease in capsule endoscopy videos: A deep learning approach","authors":"Luís Pinto ,&nbsp;Isabel N. Figueiredo ,&nbsp;Pedro N. Figueiredo","doi":"10.1016/j.ijmedinf.2025.105792","DOIUrl":"10.1016/j.ijmedinf.2025.105792","url":null,"abstract":"<div><h3>Background</h3><div>The wireless capsule endoscope (CE) is a valuable diagnostic tool in gastroenterology, offering a safe and minimally invasive visualization of the gastrointestinal tract. One of the few drawbacks identified by the gastroenterology community is the time-consuming task of analyzing CE videos.</div></div><div><h3>Objectives</h3><div>This article investigates the feasibility of a computer-aided diagnostic method to speed up CE video analysis. We aim to generate a significantly smaller CE video with all the anomalies (i.e., diseases) identified by the medical doctors in the original video.</div></div><div><h3>Methods</h3><div>The summarized video consists of the original video frames classified as anomalous by a pre-trained convolutional neural network (CNN). We evaluate our approach on a testing dataset with eight CE videos captured with five CE types and displaying multiple anomalies.</div></div><div><h3>Results</h3><div>On average, the summarized videos contain 93.33% of the anomalies identified in the original videos. The average playback time of the summarized videos is just 10 min, compared to 58 min for the original videos.</div></div><div><h3>Conclusion</h3><div>Our findings demonstrate the potential of deep learning-aided diagnostic methods to accelerate CE video analysis.</div></div>","PeriodicalId":54950,"journal":{"name":"International Journal of Medical Informatics","volume":"195 ","pages":"Article 105792"},"PeriodicalIF":3.7,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a drug allergy alert tiering algorithm for penicillins and cephalosporins
IF 3.7 2区 医学 Q2 COMPUTER SCIENCE, INFORMATION SYSTEMS Pub Date : 2025-01-10 DOI: 10.1016/j.ijmedinf.2025.105789
Rachel L. Wasserman , Heba H. Edrees , Diane L. Seger , Foster R. Goss , Kimberly G. Blumenthal , Ying-Chih Lo , Suzanne Blackley , David W. Bates , Li Zhou

Introduction

Limited research is available regarding recommendations about which drug allergy alerts (DAAs) in clinical decision support (CDS) systems should interrupt provider workflow. The objective was to evaluate the frequency of penicillin and cephalosporin DAA overrides at two institutions. A secondary objective was to redesign DAAs using a new tiered alerting system based on patient factors.

Methods

A retrospective, observational study evaluated CDS DAA overrides for penicillins and cephalosporins at two large academic medical centers. Included patients were at least 18 years of age and had a penicillin or cephalosporin DAA fired at the time of medication ordering. We developed a rule-based algorithm to classify DAAs into three groups: no alerts presented to user, non-interruptive (informational) alerts, and interruptive alerts requiring a coded response. The rule-based algorithm includes drug class or cross-sensitivity matches and reaction types with designated severities (high, medium, or low).

Results

DAAs for penicillin and cephalosporins were overridden 55% of the time at each institution. Of the DAAs overrides, 85% were cross sensitivity matches and 15% were drug class matches. Reactions were classified as 22% high severity, 29% medium, and 48% low. Most low severity reactions were rash (25%), unspecified reactions with no comments (13%), nausea/vomiting (4%), and GI upset (3%). High severity reactions were mostly other reactions with comments (19%) and anaphylaxis (4%). Approximately 30% of the penicillin and cephalosporin alert overrides could have been non-interruptive alerts based on the penicillin or cephalosporin allergic reaction documented in the EHR at each institution.

Conclusion

The majority of penicillin and cephalosporin DAAs were overridden, largely for cross sensitivity in lower severity reactions. The data can be used to inform DAA redesign, reduce override rates, and improve patient safety.
{"title":"Development of a drug allergy alert tiering algorithm for penicillins and cephalosporins","authors":"Rachel L. Wasserman ,&nbsp;Heba H. Edrees ,&nbsp;Diane L. Seger ,&nbsp;Foster R. Goss ,&nbsp;Kimberly G. Blumenthal ,&nbsp;Ying-Chih Lo ,&nbsp;Suzanne Blackley ,&nbsp;David W. Bates ,&nbsp;Li Zhou","doi":"10.1016/j.ijmedinf.2025.105789","DOIUrl":"10.1016/j.ijmedinf.2025.105789","url":null,"abstract":"<div><h3>Introduction</h3><div>Limited research is available regarding recommendations about which drug allergy alerts (DAAs) in clinical decision support (CDS) systems should interrupt provider workflow. The objective was to evaluate the frequency of penicillin and cephalosporin DAA overrides at two institutions. A secondary objective was to redesign DAAs using a new tiered alerting system based on patient factors.</div></div><div><h3>Methods</h3><div>A retrospective, observational study evaluated CDS DAA overrides for penicillins and cephalosporins at two large academic medical centers. Included patients were at least 18 years of age and had a penicillin or cephalosporin DAA fired at the time of medication ordering. We developed a rule-based algorithm to classify DAAs into three groups: no alerts presented to user, non-interruptive (informational) alerts, and interruptive alerts requiring a coded response. The rule-based algorithm includes drug class or cross-sensitivity matches and reaction types with designated severities (high, medium, or low).</div></div><div><h3>Results</h3><div>DAAs for penicillin and cephalosporins were overridden 55% of the time at each institution. Of the DAAs overrides, 85% were cross sensitivity matches and 15% were drug class matches. Reactions were classified as 22% high severity, 29% medium, and 48% low. Most low severity reactions were rash (25%), unspecified reactions with no comments (13%), nausea/vomiting (4%), and GI upset (3%). High severity reactions were mostly other reactions with comments (19%) and anaphylaxis (4%). Approximately 30% of the penicillin and cephalosporin alert overrides could have been non-interruptive alerts based on the penicillin or cephalosporin allergic reaction documented in the EHR at each institution.</div></div><div><h3>Conclusion</h3><div>The majority of penicillin and cephalosporin DAAs were overridden, largely for cross sensitivity in lower severity reactions. The data can be used to inform DAA redesign, reduce override rates, and improve patient safety.</div></div>","PeriodicalId":54950,"journal":{"name":"International Journal of Medical Informatics","volume":"195 ","pages":"Article 105789"},"PeriodicalIF":3.7,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143030306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utilizing artificial intelligence and cellular population data for timely identification of bacteremia in hospitalized patients 利用人工智能和细胞群数据及时识别住院患者的菌血症。
IF 3.7 2区 医学 Q2 COMPUTER SCIENCE, INFORMATION SYSTEMS Pub Date : 2025-01-10 DOI: 10.1016/j.ijmedinf.2025.105788
Wei-Hsun Chen , Yu-Hsin Chang , Chiung-Tzu Hsiao , Po-Ren Hsueh , Hong-Mo Shih

Background

Bacteremia is a critical condition with high mortality that requires prompt detection to prevent progression to life-threatening sepsis. Traditional diagnostic approaches, such as blood cultures, are time-consuming. This limitation has encouraged the exploration of rapid prediction methodologies. Cellular Population Data (CPD), which provides detailed insights into white blood cell morphology and functionality, is a promising technique for the early detection of bacteremia.

Methods

This study applied machine learning models to analyze laboratory data from hospitalized patients at risk of bacteremia from three hospitals. Using complete blood count (CBC), differential count (DC), and CPD, collected at various time intervals, we trained two sets of artificial intelligence models: one trained using data from patients in the Emergency Department (ED) and another specifically designed for and trained using data from a hospitalized cohort. We evaluated the performance of both models by applying them to the same hospitalized population and comparing their outcomes.

Results

The study encompassed analysis of over 66,000 CBC samples. The model tailored for hospitalized patients exhibited superior performance in bacteremia prediction across all cohorts compared with the ED-model, achieving an area under the receiver operating characteristic curve (AUROC) of 0.772 in the validation cohort from China Medical University Hospital and 0.808 and 0.843 in two other hospital cohorts. Notably, nearly half of the top fifteen important features identified by shapely additive explanations values were CPD parameters, underscoring the pivotal role of CPD in predictive models for bacteremia.

Conclusions

Artificial intelligence models incorporating CPD data can accurately predict bacteremia in hospitalized patients. Models specifically trained on hospitalized patient data demonstrate enhanced performance over those based on ED data in predicting bacteremia occurrences. Future research must explore the clinical effects of these models, focusing on their potential to assist physicians in managing antibiotic use and patient health.
背景:菌血症是一种死亡率高的危重疾病,需要及时发现以防止进展为危及生命的败血症。传统的诊断方法,如血液培养,是耗时的。这种限制鼓励了对快速预测方法的探索。细胞群数据(CPD)提供了白细胞形态和功能的详细见解,是早期检测菌血症的一种很有前途的技术。方法:本研究应用机器学习模型对三家医院有菌血症风险的住院患者的实验室数据进行分析。使用在不同时间间隔收集的全血细胞计数(CBC)、差异计数(DC)和CPD,我们训练了两组人工智能模型:一组使用急诊科(ED)患者的数据进行训练,另一组专门为住院队列设计并使用数据进行训练。我们通过将两种模型应用于同一住院人群并比较其结果来评估两种模型的性能。结果:该研究分析了超过66,000个CBC样本。与ed模型相比,为住院患者量身定制的模型在所有队列中的菌血症预测表现优于ed模型,在中国医科大学医院的验证队列中,受试者工作特征曲线下面积(AUROC)为0.772,在其他两个医院队列中,AUROC为0.808和0.843。值得注意的是,在形状加法解释值确定的前15个重要特征中,近一半是CPD参数,强调了CPD在菌血症预测模型中的关键作用。结论:结合CPD数据的人工智能模型可以准确预测住院患者的菌血症。根据住院患者数据专门训练的模型在预测菌血症发生率方面比基于ED数据的模型表现更好。未来的研究必须探索这些模型的临床效果,重点关注它们在帮助医生管理抗生素使用和患者健康方面的潜力。
{"title":"Utilizing artificial intelligence and cellular population data for timely identification of bacteremia in hospitalized patients","authors":"Wei-Hsun Chen ,&nbsp;Yu-Hsin Chang ,&nbsp;Chiung-Tzu Hsiao ,&nbsp;Po-Ren Hsueh ,&nbsp;Hong-Mo Shih","doi":"10.1016/j.ijmedinf.2025.105788","DOIUrl":"10.1016/j.ijmedinf.2025.105788","url":null,"abstract":"<div><h3>Background</h3><div>Bacteremia is a critical condition with high mortality that requires prompt detection to prevent progression to life-threatening sepsis. Traditional diagnostic approaches, such as blood cultures, are time-consuming. This limitation has encouraged the exploration of rapid prediction methodologies. Cellular Population Data (CPD), which provides detailed insights into white blood cell morphology and functionality, is a promising technique for the early detection of bacteremia.</div></div><div><h3>Methods</h3><div>This study applied machine learning models to analyze laboratory data from hospitalized patients at risk of bacteremia from three hospitals. Using complete blood count (CBC), differential count (DC), and CPD, collected at various time intervals, we trained two sets of artificial intelligence models: one trained using data from patients in the Emergency Department (ED) and another specifically designed for and trained using data from a hospitalized cohort. We evaluated the performance of both models by applying them to the same hospitalized population and comparing their outcomes.</div></div><div><h3>Results</h3><div>The study encompassed analysis of over 66,000 CBC samples. The model tailored for hospitalized patients exhibited superior performance in bacteremia prediction across all cohorts compared with the ED-model, achieving an area under the receiver operating characteristic curve (AUROC) of 0.772 in the validation cohort from China Medical University Hospital and 0.808 and 0.843 in two other hospital cohorts. Notably, nearly half of the top fifteen important features identified by shapely additive explanations values were CPD parameters, underscoring the pivotal role of CPD in predictive models for bacteremia.</div></div><div><h3>Conclusions</h3><div>Artificial intelligence models incorporating CPD data can accurately predict bacteremia in hospitalized patients. Models specifically trained on hospitalized patient data demonstrate enhanced performance over those based on ED data in predicting bacteremia occurrences. Future research must explore the clinical effects of these models, focusing on their potential to assist physicians in managing antibiotic use and patient health.</div></div>","PeriodicalId":54950,"journal":{"name":"International Journal of Medical Informatics","volume":"195 ","pages":"Article 105788"},"PeriodicalIF":3.7,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring tele-speech therapy: A scoping review of interventions, applications, benefits, and challenges 探索远程言语治疗:干预、应用、益处和挑战的范围审查。
IF 3.7 2区 医学 Q2 COMPUTER SCIENCE, INFORMATION SYSTEMS Pub Date : 2025-01-08 DOI: 10.1016/j.ijmedinf.2025.105784
Khadijeh Moulaei , Fatemeh Dinari , Mobina Hosseini , Sohrab Almasi , Babak Sabet , Romina Anabestani , Mohammad Reza Afrash

Background

Speech disorders can significantly impact communication, social interaction, and overall quality of life, affecting individuals of all ages. Telespeech therapy has emerged as an innovative solution, leveraging technology to provide accessible and effective speech interventions remotely. This approach offers flexibility and convenience, addressing barriers such as geographical limitations and scheduling conflicts. This review aims to explore key interventions, applications, benefits, and challenges of telespeech therapy to enhance understanding of its potential in improving speech and language outcomes.

Methods

The scoping review was carried out in alignment with the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) guidelines. Three electronic databases PubMed, Scopus, and Web of Science were searched. Two authors independently screened and selected the studies.

Results

Of the 2,587 papers, 52 articles were included in our review. Telespeech was most commonly used for treating aphasia (n = 17), stuttering (n = 8), and Parkinson’s disease (n = 6). The primary interventions included videoconferencing (63 %), web-based platforms (24 %), and mobile applications (13 %), with most services delivered synchronously (63 %) and some asynchronously (37 %). The most common applications were “rehabilitation and treatment” (59 %) and “performance assessment of patients”(35 %). A total of 264 tele-speech benefits and challenges were identified and later consolidated into 40 items (26 benefits, 14 challenges). Key benefits included “reliable access to healthcare services and addressing disparities” (n = 26), “cost savings” (n = 23), and “improving patient outcomes and quality of care” (n = 21). Major challenges were “low-speed internet” (n = 13), “lack of technology skills” (n = 11), and “limited access to technology” (n = 8).

Conclusion

Telespeech therapy can be effectively integrated into routine practice, especially in underserved or remote areas. It offers a flexible, cost-effective solution for rehabilitation and performance assessment, improving patient outcomes and addressing healthcare gaps. Continued technological advancements and targeted training can further enhance its benefits and effectiveness.
背景:语言障碍可以显著影响沟通、社会互动和整体生活质量,影响所有年龄段的个体。远程语音治疗已经成为一种创新的解决方案,利用技术提供可访问和有效的远程语音干预。这种方法提供了灵活性和便利性,解决了地理限制和调度冲突等障碍。本文旨在探讨远程语音治疗的主要干预措施、应用、益处和挑战,以加深对其改善语音和语言预后潜力的理解。方法:根据PRISMA-ScR(系统评价和荟萃分析扩展范围评价的首选报告项目)指南进行范围评价。检索了PubMed、Scopus和Web of Science三个电子数据库。两位作者独立筛选和选择了这些研究。结果:2587篇论文中,52篇被纳入我们的综述。远程演讲最常用于治疗失语症(n = 17)、口吃(n = 8)和帕金森病(n = 6)。主要干预措施包括视频会议(63%)、网络平台(24%)和移动应用程序(13%),其中大多数服务同步提供(63%),一些异步提供(37%)。最常见的应用是“康复和治疗”(59%)和“患者绩效评估”(35%)。共确定了264个远程语音利益和挑战,后来将其合并为40个项目(26个利益,14个挑战)。主要益处包括“获得可靠的医疗保健服务和解决差异”(n = 26)、“节省成本”(n = 23)和“改善患者的治疗结果和护理质量”(n = 21)。主要挑战是“网速低”(n = 13)、“缺乏技术技能”(n = 11)和“获取技术的机会有限”(n = 8)。结论:远程语音治疗可以有效地融入日常实践,特别是在服务不足或偏远地区。它为康复和绩效评估提供了一种灵活的、具有成本效益的解决方案,改善了患者的治疗效果,并解决了医疗保健差距。持续的技术进步和有针对性的培训可以进一步提高其效益和有效性。
{"title":"Exploring tele-speech therapy: A scoping review of interventions, applications, benefits, and challenges","authors":"Khadijeh Moulaei ,&nbsp;Fatemeh Dinari ,&nbsp;Mobina Hosseini ,&nbsp;Sohrab Almasi ,&nbsp;Babak Sabet ,&nbsp;Romina Anabestani ,&nbsp;Mohammad Reza Afrash","doi":"10.1016/j.ijmedinf.2025.105784","DOIUrl":"10.1016/j.ijmedinf.2025.105784","url":null,"abstract":"<div><h3>Background</h3><div>Speech disorders can significantly impact communication, social interaction, and overall quality of life, affecting individuals of all ages. Telespeech therapy has emerged as an innovative solution, leveraging technology to provide accessible and effective speech interventions remotely. This approach offers flexibility and convenience, addressing barriers such as geographical limitations and scheduling conflicts. This review aims to explore key interventions, applications, benefits, and challenges of telespeech therapy to enhance understanding of its potential in improving speech and language outcomes.</div></div><div><h3>Methods</h3><div>The scoping review was carried out in alignment with the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) guidelines. Three electronic databases PubMed, Scopus, and Web of Science were searched. Two authors independently screened and selected the studies.</div></div><div><h3>Results</h3><div>Of the 2,587 papers, 52 articles were included in our review. Telespeech was most commonly used for treating aphasia (n = 17), stuttering (n = 8), and Parkinson’s disease (n = 6). The primary interventions included videoconferencing (63 %), web-based platforms (24 %), and mobile applications (13 %), with most services delivered synchronously (63 %) and some asynchronously (37 %). The most common applications were “rehabilitation and treatment” (59 %) and “performance assessment of patients”(35 %). A total of 264 tele-speech benefits and challenges were identified and later consolidated into 40 items (26 benefits, 14 challenges). Key benefits included “reliable access to healthcare services and addressing disparities” (n = 26), “cost savings” (n = 23), and “improving patient outcomes and quality of care” (n = 21). Major challenges were “low-speed internet” (n = 13), “lack of technology skills” (n = 11), and “limited access to technology” (n = 8).</div></div><div><h3>Conclusion</h3><div>Telespeech therapy can be effectively integrated into routine practice, especially in underserved or remote areas. It offers a flexible, cost-effective solution for rehabilitation and performance assessment, improving patient outcomes and addressing healthcare gaps. Continued technological advancements and targeted training can further enhance its benefits and effectiveness.</div></div>","PeriodicalId":54950,"journal":{"name":"International Journal of Medical Informatics","volume":"195 ","pages":"Article 105784"},"PeriodicalIF":3.7,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142967401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of the COVID-19 pandemic on mHealth adoption: Identification of the main barriers through an international comparative analysis COVID-19大流行对移动医疗采用的影响:通过国际比较分析确定主要障碍。
IF 3.7 2区 医学 Q2 COMPUTER SCIENCE, INFORMATION SYSTEMS Pub Date : 2025-01-06 DOI: 10.1016/j.ijmedinf.2024.105779
Ana Jiménez-Zarco , Sergio Cámara Mateos , Marina Bosque-Prous , Albert Espelt , Joan Torrent-Sellens , Keyrellous Adib , Karapet Davtyan , Ryan Dos Santos , Francesc Saigí-Rubió

Background

The COVID-19 pandemic greatly challenged health systems worldwide. The adoption and application of mHealth technology emerged as a critical response. However, the permanent implementation and use of such technology faces several barriers, which vary by each country’s innovation level and specific health policies. This study provides a detailed analysis of the transformations in mHealth service implementation within the context of the COVID-19 pandemic.

Objectives

The study analyses the changes to mHealth service implementation during the COVID-19 pandemic. It seeks to identify the main uses of technology in mHealth, to assess their level of adoption, and to address any barriers found. It also aims to compare different countries to understand how factors such as geographical location and public health policies affect mHealth status worldwide.

Methods

The survey tool was a revised version of the World Health Organization (WHO) 2015 Global Survey on eHealth, which had been updated to reflect the latest advances and policy priorities. The 2022 Survey on Digital Health in the WHO European Region was conducted by the WHO between April and October 2022 to gather information from the Member States of that region.

Results

This study shows that across the countries analysed, significant variations occurred in mHealth service adoption during the pandemic. Teleconsultation, access to patient information, and appointment reminders were the most implemented services, highlighting the importance of remote care during health crises. Regional differences were identified regarding barriers such as privacy and security and patient digital literacy, underscoring the need to address such shortcomings. These conclusions have important implications for stakeholders in the digital health sector and emphasise the need for collaboration to address the identified challenges.
背景:2019冠状病毒病大流行给全球卫生系统带来了巨大挑战。移动医疗技术的采用和应用成为关键的应对措施。然而,这些技术的长期实施和使用面临着若干障碍,这些障碍因每个国家的创新水平和具体的卫生政策而异。本研究详细分析了COVID-19大流行背景下移动医疗服务实施的转变。目的:本研究分析了COVID-19大流行期间移动医疗服务实施的变化。它旨在确定移动医疗技术的主要用途,评估其采用程度,并解决发现的任何障碍。它还旨在比较不同的国家,以了解地理位置和公共卫生政策等因素如何影响全球移动健康状况。方法:调查工具是世界卫生组织(WHO) 2015年全球电子卫生调查的修订版,该调查已更新,以反映最新进展和政策重点。世卫组织于2022年4月至10月期间进行了世卫组织欧洲区域2022年数字卫生调查,以收集该区域会员国的信息。结果:本研究表明,在所分析的国家中,大流行期间移动医疗服务的采用发生了显著变化。远程咨询、获取患者信息和预约提醒是实施最多的服务,突出了健康危机期间远程护理的重要性。在隐私和安全以及患者数字素养等障碍方面发现了区域差异,强调需要解决这些缺点。这些结论对数字卫生部门的利益攸关方具有重要意义,并强调需要开展合作,以应对已确定的挑战。
{"title":"Impact of the COVID-19 pandemic on mHealth adoption: Identification of the main barriers through an international comparative analysis","authors":"Ana Jiménez-Zarco ,&nbsp;Sergio Cámara Mateos ,&nbsp;Marina Bosque-Prous ,&nbsp;Albert Espelt ,&nbsp;Joan Torrent-Sellens ,&nbsp;Keyrellous Adib ,&nbsp;Karapet Davtyan ,&nbsp;Ryan Dos Santos ,&nbsp;Francesc Saigí-Rubió","doi":"10.1016/j.ijmedinf.2024.105779","DOIUrl":"10.1016/j.ijmedinf.2024.105779","url":null,"abstract":"<div><h3>Background</h3><div>The COVID-19 pandemic greatly challenged health systems worldwide. The adoption and application of mHealth technology emerged as a critical response. However, the permanent implementation and use of such technology faces several barriers, which vary by each country’s innovation level and specific health policies. This study provides a detailed analysis of the transformations in mHealth service implementation within the context of the COVID-19 pandemic.</div></div><div><h3>Objectives</h3><div>The study analyses the changes to mHealth service implementation during the COVID-19 pandemic. It seeks to identify the main uses of technology in mHealth, to assess their level of adoption, and to address any barriers found. It also aims to compare different countries to understand how factors such as geographical location and public health policies affect mHealth status worldwide.</div></div><div><h3>Methods</h3><div>The survey tool was a revised version of the World Health Organization (WHO) 2015 Global Survey on eHealth, which had been updated to reflect the latest advances and policy priorities. The 2022 Survey on Digital Health in the WHO European Region was conducted by the WHO between April and October 2022 to gather information from the Member States of that region.</div></div><div><h3>Results</h3><div>This study shows that across the countries analysed, significant variations occurred in mHealth service adoption during the pandemic. Teleconsultation, access to patient information, and appointment reminders were the most implemented services, highlighting the importance of remote care during health crises. Regional differences were identified regarding barriers such as privacy and security and patient digital literacy, underscoring the need to address such shortcomings. These conclusions have important implications for stakeholders in the digital health sector and emphasise the need for collaboration to address the identified challenges.</div></div>","PeriodicalId":54950,"journal":{"name":"International Journal of Medical Informatics","volume":"195 ","pages":"Article 105779"},"PeriodicalIF":3.7,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Medical Informatics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1